Showing 2,681 - 2,700 results of 64,337 for search '(( 5 ((wt decrease) OR (we decrease)) ) OR ( 50 ((mean decrease) OR (a decrease)) ))', query time: 0.85s Refine Results
  1. 2681
  2. 2682
  3. 2683
  4. 2684
  5. 2685

    <i>skn-1b</i> is not required for WT or <i>daf-2</i> longevity A-F) Survival of WT and <i>skn-1b</i> mutants in the absence and presence of <i>daf-2</i> mutation. by Nikolaos Tataridas-Pallas (10231350)

    Published 2021
    “…In a total of 15 trials (13 on OP50, 2 on HT115) bacteria we observed a slight decrease in <i>skn-1b</i> longevity compared to WT in 4 trials (<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1009358#pgen.1009358.s004" target="_blank">S4</a> and <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1009358#pgen.1009358.s005" target="_blank">S5</a> Tables). …”
  6. 2686
  7. 2687

    The expression and localization of the WT and <i>CACNA1C-</i>Q1916R channels in HEK293T cells. by Xin Liu (43569)

    Published 2017
    “…<p>(A-B) Expression levels of WT and mutant of Ca<sub>V</sub>1.2α1C in the intact cell, membrane fraction and cytoplasmic fraction of the HEK293T cells. …”
  8. 2688
  9. 2689
  10. 2690

    Data_Sheet_1_Decrease in COVID-19 adverse outcomes in adults during the Delta and Omicron SARS-CoV-2 waves, after vaccination in Mexico.docx by Lenin Domínguez-Ramírez (481547)

    Published 2022
    “…In this scenario of high SARS-CoV-2 circulation, we analyzed the effectiveness of the country's vaccination strategy that used 7 different vaccines from around the world, and focused on vaccinating the oldest population first. …”
  11. 2691
  12. 2692

    Image_5_Catheter-Based Therapies Decrease Mortality in Patients With Intermediate and High-Risk Pulmonary Embolism: Evidence From Meta-Analysis of 65,589 Patients.TIF by Arkadiusz Pietrasik (12879863)

    Published 2022
    “…Extracorporeal life support was used more often in patients treated with CDT, compared to ST (0.5 vs. 0.2%, OR = 2.52, 95% CI 1.88–3.39, p < 0.001). …”
  13. 2693
  14. 2694
  15. 2695

    The ASEL neuron functions in glucose attraction after glucose conditioning. by Masahiro Tomioka (430683)

    Published 2023
    “…The glucose concentration was switched from 15 to 0 mM at 50 s and then returned to 15 mM at 100 s. Quantification of calcium responses of ASEL upon decrease in glucose concentration (D). …”
  16. 2696
  17. 2697

    Treatment outcomes. by Shaghayegh Khanmohammadi (14598182)

    Published 2023
    “…The rate of local recurrence in the included studies ranged from 9.4% to 78%, and local control progression-free survival ranged from 1 to 31 months. The total QoL decreased one week after the cryoablation procedure (-3.08 [95% Confidence interval: -4.65, -1.50], p-value <0.01) but increased one month (5.69 [3.99, 7.39], p-value <0.01) and three months (3.75 [2.25, 5.24], p-value <0.01) after the procedure.…”
  18. 2698

    Quality assessment of included papers. by Shaghayegh Khanmohammadi (14598182)

    Published 2023
    “…The rate of local recurrence in the included studies ranged from 9.4% to 78%, and local control progression-free survival ranged from 1 to 31 months. The total QoL decreased one week after the cryoablation procedure (-3.08 [95% Confidence interval: -4.65, -1.50], p-value <0.01) but increased one month (5.69 [3.99, 7.39], p-value <0.01) and three months (3.75 [2.25, 5.24], p-value <0.01) after the procedure.…”
  19. 2699

    Basic characteristics of the included studies. by Shaghayegh Khanmohammadi (14598182)

    Published 2023
    “…The rate of local recurrence in the included studies ranged from 9.4% to 78%, and local control progression-free survival ranged from 1 to 31 months. The total QoL decreased one week after the cryoablation procedure (-3.08 [95% Confidence interval: -4.65, -1.50], p-value <0.01) but increased one month (5.69 [3.99, 7.39], p-value <0.01) and three months (3.75 [2.25, 5.24], p-value <0.01) after the procedure.…”
  20. 2700